The story of Viagra and the pharmaceutical industry presents a intricate picture for prospective investors. Initially, copyright's hugely successful drug revolutionized the treatment of erectile dysfunction, producing substantial profits and defining the contemporary pharmaceutical landscape. However, exclusive rights expiration and the emergence o